Health
Researchers develop α-emitting cancer therapy using a novel drug targeting LAT1 – News-Medical.Net
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues.
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.
The researchers first produced the alpha-ray emitter 211Astatine, no easy task given that Astatine…
-
General23 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
Noosa News23 hours agoLord mayor promises to review medium density planning laws
-
Noosa News15 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General12 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay